MIST logo

MIST Stock Overview

Profile

Full Name:

Milestone Pharmaceuticals Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

May 9, 2019

Indexes:

Not included

Description:

Milestone Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for cardiovascular diseases. Their main product, etripamil, is designed to provide rapid relief for patients experiencing paroxysmal supraventricular tachycardia (PSVT). The company aims to improve patient care through effective and convenient therapies.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Oct 14, 24 HC Wainwright & Co.
Buy
Aug 22, 24 Rodman & Renshaw
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Jul 1, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy
May 16, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Mar 5, 24 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Milestone Pharmaceuticals?
  • Does Milestone Pharmaceuticals pay dividends?
  • What sector is Milestone Pharmaceuticals in?
  • What industry is Milestone Pharmaceuticals in?
  • What country is Milestone Pharmaceuticals based in?
  • When did Milestone Pharmaceuticals go public?
  • Is Milestone Pharmaceuticals in the S&P 500?
  • Is Milestone Pharmaceuticals in the NASDAQ 100?
  • Is Milestone Pharmaceuticals in the Dow Jones?
  • When was Milestone Pharmaceuticals's last earnings report?
  • When does Milestone Pharmaceuticals report earnings?
  • Should I buy Milestone Pharmaceuticals stock now?

What is the ticker symbol for Milestone Pharmaceuticals?

The ticker symbol for Milestone Pharmaceuticals is NASDAQ:MIST

Does Milestone Pharmaceuticals pay dividends?

No, Milestone Pharmaceuticals does not pay dividends

What sector is Milestone Pharmaceuticals in?

Milestone Pharmaceuticals is in the Healthcare sector

What industry is Milestone Pharmaceuticals in?

Milestone Pharmaceuticals is in the Biotechnology industry

What country is Milestone Pharmaceuticals based in?

Milestone Pharmaceuticals is headquartered in Canada

When did Milestone Pharmaceuticals go public?

Milestone Pharmaceuticals's initial public offering (IPO) was on May 9, 2019

Is Milestone Pharmaceuticals in the S&P 500?

No, Milestone Pharmaceuticals is not included in the S&P 500 index

Is Milestone Pharmaceuticals in the NASDAQ 100?

No, Milestone Pharmaceuticals is not included in the NASDAQ 100 index

Is Milestone Pharmaceuticals in the Dow Jones?

No, Milestone Pharmaceuticals is not included in the Dow Jones index

When was Milestone Pharmaceuticals's last earnings report?

Milestone Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Milestone Pharmaceuticals report earnings?

The next expected earnings date for Milestone Pharmaceuticals is Mar 21, 2025

Should I buy Milestone Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions